TSX:TLRY • US88688T2096
The current stock price of TLRY.CA is 10.16 CAD. In the past month the price decreased by -25.13%. In the past year, price decreased by -23.03%.
ChartMill assigns a fundamental rating of 2 / 10 to TLRY.CA. TLRY.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months TLRY.CA reported a non-GAAP Earnings per Share(EPS) of -19.49. The EPS decreased by -379% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.42% | ||
| ROE | -133.4% | ||
| Debt/Equity | 0.18 |
16 analysts have analysed TLRY.CA and the average price target is 17.33 CAD. This implies a price increase of 70.59% is expected in the next year compared to the current price of 10.16.
For the next year, analysts expect an EPS growth of 96.56% and a revenue growth 3.75% for TLRY.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.37 | 3.063B | ||
| GSD | DEVONIAN HEALTH GROUP INC | N/A | 1.975B | ||
| CRON | CRONOS GROUP INC | 36.35 | 1.363B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 6.9 | 872.942M | ||
| GUD | KNIGHT THERAPEUTICS INC | 124.44 | 585.811M | ||
| WEED | CANOPY GROWTH CORP | N/A | 534.267M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 408.258M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 26.58 | 360.761M | ||
| TSND | TERRASCEND CORP | N/A | 313.013M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
TILRAY BRANDS INC
265 Talbot Street West
Leamington ONTARIO V9X 1J2 CA
CEO: Manfred Ziegler
Employees: 2842
Phone: 13026365400
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
The current stock price of TLRY.CA is 10.16 CAD. The price decreased by -2.03% in the last trading session.
TLRY.CA does not pay a dividend.
TLRY.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
16 analysts have analysed TLRY.CA and the average price target is 17.33 CAD. This implies a price increase of 70.59% is expected in the next year compared to the current price of 10.16.
TILRAY BRANDS INC (TLRY.CA) operates in the Health Care sector and the Pharmaceuticals industry.